Holdings of FARALLON CAPITAL MANAGEMENT LLC
148 declared positions · as of Mar 31, 2026
Original filing · Ten largest lines: 51 % of the equity sleeve
Sector breakdown
- Health care 18.2 %
- Technology 13.6 %
- Financials 9.2 %
- Consumer discretionary 6.3 %
- Communication 3.9 %
- Industrials 3.0 %
- Real estate 0.3 %
- Unattributed 45.5 %
Titelia classification, company by company. The unattributed share stays visible.
Currency breakdown
The quoted currency of each line, as declared.
Country breakdown
- US 99.4 %
- KY 0.3 %
- DK 0.2 %
- IL 0.1 %
- ES 0.0 %
- FR 0.0 %
Shares computed on the equity sleeve.
| Rank | Country | Lines | Value | Share |
|---|
| 1 | US | 141 | 14B $ | 99.40 % |
| 2 | KY | 3 | 44.6M $ | 0.32 % |
| 3 | DK | 1 | 28.7M $ | 0.20 % |
| 4 | IL | 1 | 10.7M $ | 0.08 % |
| 5 | ES | 1 | 224.6K $ | 0.00 % |
| 6 | FR | 1 | 222.7K $ | 0.00 % |
Positions
| Rank | Company | Shares | Value | Weight |
|---|
| 101 | Progyny Inc | 18,000 | 305.6K $ | |
| 102 | Stoke Therapeutics Inc | 9,000 | 293K $ | |
| 103 | Erasca Inc | 18,000 | 291.2K $ | |
| 104 | Encompass Health Corp | 3,000 | 290.2K $ | |
| 105 | Nektar Therapeutics | 4,000 | 287.8K $ | |
| 106 | Glaukos Corp | 2,600 | 279.9K $ | |
| 107 | Mirum Pharmaceuticals Inc | 3,000 | 277.1K $ | |
| 108 | Sabra Health Care REIT Inc | 14,000 | 269.2K $ | |
| 109 | Krystal Biotech Inc | 1,000 | 258.3K $ | |
| 110 | Omeros Corp | 23,000 | 242.9K $ | |
| 111 | Alumis Inc | 11,000 | 242.3K $ | |
| 112 | Apellis Pharmaceuticals Inc | 6,000 | 241.4K $ | |
| 113 | HealthEquity Inc | 2,800 | 234K $ | |
| 114 | Syndax Pharmaceuticals Inc | 10,000 | 233.6K $ | |
| 115 | Amicus Therapeutics Inc | 16,000 | 231.4K $ | |
| 116 | BioCryst Pharmaceuticals Inc | 24,000 | 228.5K $ | |
| 117 | Veracyte Inc | 7,000 | 225.5K $ | |
| 118 | Grifols SA | 28,000 | 224.6K $ | |
| 119 | Abivax SA | 2,000 | 222.7K $ | |
| 120 | GE HealthCare Technologies Inc | 3,000 | 213.5K $ | |
| 121 | REVOLUTION MEDICINES INC WTS 12/26 | 120,085 | 208.9K $ | |
| 122 | Hims & Hers Health Inc | 10,000 | 207.6K $ | |
| 123 | Belite Bio Inc | 1,300 | 207.3K $ | |
| 124 | Merit Medical Systems Inc | 3,000 | 206.8K $ | |
| 125 | Supernus Pharmaceuticals Inc | 4,000 | 206.8K $ | |
| 126 | Healthcare Realty Trust Inc | 12,000 | 203.9K $ | |
| 127 | Vir Biotechnology Inc | 22,000 | 197.1K $ | |
| 128 | Precigen Inc | 50,000 | 193.5K $ | |
| 129 | Schrodinger Inc/United States | 17,000 | 193.1K $ | |
| 130 | Dyne Therapeutics Inc | 10,000 | 181.3K $ | |
| 131 | Novavax Inc | 22,000 | 179.1K $ | |
| 132 | Pacific Biosciences of California Inc | 135,000 | 178.2K $ | |
| 133 | SELLAS Life Sciences Group Inc | 40,000 | 169.2K $ | |
| 134 | Adaptive Biotechnologies Corp | 11,000 | 152.7K $ | |
| 135 | Ocular Therapeutix Inc | 18,000 | 152.5K $ | |
| 136 | NeoGenomics Inc | 19,000 | 141K $ | |
| 137 | Ardelyx Inc | 23,000 | 137.8K $ | |
| 138 | Oscar Health Inc | 11,000 | 126.2K $ | |
| 139 | Nuvation Bio Inc | 29,000 | 124.4K $ | |
| 140 | Iovance Biotherapeutics Inc | 26,000 | 91.3K $ | |
| 141 | Altimmune Inc | 27,600 | 85K $ | |
| 142 | C4 Therapeutics Inc | 28,000 | 73.6K $ | |
| 143 | Tvardi Therapeutics Inc | 21,438 | 68.2K $ | |
| 144 | Geron Corp | 43,000 | 64.1K $ | |
| 145 | Rani Therapeutics Holdings Inc | 78,000 | 57.3K $ | |
| 146 | Ironwood Pharmaceuticals Inc | 13,000 | 45.6K $ | |
| 147 | Evolent Health Inc | 14,000 | 31.9K $ | |
| 148 | Beyond Meat Inc | 19,000 | 13.3K $ | |